Copyright
©The Author(s) 2016.
World J Gastroenterol. Oct 14, 2016; 22(38): 8480-8488
Published online Oct 14, 2016. doi: 10.3748/wjg.v22.i38.8480
Published online Oct 14, 2016. doi: 10.3748/wjg.v22.i38.8480
Figure 1 Liquid biopsy for pancreatic cancer.
Circulating tumor DNA (ctDNA) can be isolated from plasma as a liquid biopsy approach. Genomic alterations detected could then have various clinical applications in pancreatic cancer cases. As ctDNA is released not only from primary tumors, but also metastases, its analysis might overcome the problem of tumor heterogeneity.
- Citation: Takai E, Yachida S. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer. World J Gastroenterol 2016; 22(38): 8480-8488
- URL: https://www.wjgnet.com/1007-9327/full/v22/i38/8480.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i38.8480